Skip to content
Recall Observatory FDA recall evidence

Drug product

Paliperidone Extended-Release Tablets, 3 mg, 90 count bottles, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, NDC: 0591-3693-19

D-0960-2017

May 31, 2017

Class I

Product summary

Firm
Teva Pharmaceuticals
Event
Event 77393
Status
Terminated
Classification
Class I
Quantity
360 bottles
Official record key
drug-enforcement:D-0960-2017

Official wording

Reason: Failed Dissolution Specifications: Drug release test result, obtained during routine 9-month stability testing, which was below specification for one tablet. Teva cannot at this time exclude the potential for additional tablets to be below specification.

Code information: Lot: 1160682A, EXP. 06/18

Distribution pattern: Nationwide in the US

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications